Medicines Co. (MDCO) Tops Q1 EPS by 2c

Medicines Co. (NASDAQ: MDCO) reported Q1 EPS of ($0.76), $0.02 better than the analyst estimate of ($0.78). Revenue for the quarter came in at $7.77 million versus the consensus estimate of $7.99 million.

For earnings history and earnings-related data on Medicines Co. (MDCO) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
• Target raises full-year sales forecast amid ongoing turnaround drive